483 Shire Human Genetic Therapies Feb 2018

483 Shire Human Genetic Therapies Feb 2018

Sean Marcsisin FDA, Edmund Mrak FDA$119.00 - Available Now

FDA investigators audited the Shire Human Genetic Therapies - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 01 Feb 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Feb 2018
  • Location: Cambridge, United States
  • FEI: 3005955297
Add To Cart